<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03876639</url>
  </required_header>
  <id_info>
    <org_study_id>SkinStudy 2019.1</org_study_id>
    <nct_id>NCT03876639</nct_id>
  </id_info>
  <brief_title>Topical Application of Highly Concentrated Water-in-oil Emulsions</brief_title>
  <official_title>Topical Application of Highly Concentrated Water-in-oil Emulsions: Physiological Skin Parameters and Skin Penetration in Vivo - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to I. determine the effect of repetitive application of newly
      developed silicone based formulations (placebo water-in-oil emulsions) on transepidermal
      water loss and other physiological skin parameters and II. investigate the skin penetration
      of the model drug fluorescein sodium in tape stripping studies to determine the in vivo
      penetration profile from the water-in-oil emulsions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Water-in-oil emulsions will be applied daily for a period of 4 weeks on the non-dominant
      volar forearm of voluntary participants. Several physiological skin parameters will be
      monitored in weekly intervals during the application period. Additional measurements will be
      carried out immediately before the start of the application and after a treatment-free
      recovery period of 2 weeks. The untreated forearm will be used as a reference.

      Subsequent to the observational study, tape stripping experiments with fluorescein
      sodium-loaded formulations will be conducted on the non-dominant forearm of the participants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2019</start_date>
  <completion_date type="Actual">March 18, 2019</completion_date>
  <primary_completion_date type="Actual">March 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in transepidermal water loss</measure>
    <time_frame>6 weeks</time_frame>
    <description>Influence of the application of the water-in-oil emulsions with different oil component - isopropyl myristate (IPM) or liquid paraffin (PAR) - on the transepidermal water loss (TEWL) using the AquaFlux Model AF200 Evaporimeter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Penetrated amount of fluorescein sodium into the skin using tape stripping/fluorescence spectroscopy</measure>
    <time_frame>week 8</time_frame>
    <description>Enhancement of the skin penetration of the model drug fluorescein sodium by the oil component isopropyl myristate in vivo using tape stripping combined with fluorescence spectroscopy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Skin Physiology</condition>
  <condition>Dermal Administration</condition>
  <condition>Emulsions</condition>
  <arm_group>
    <arm_group_label>IPM_2/18</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of formulation IPM_2/18</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAR_2/18</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of formulation PAR_2/18</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Application of emulsion</intervention_name>
    <description>Daily application of the assigned formulation on the non-dominant volar forearm for 4 weeks</description>
    <arm_group_label>IPM_2/18</arm_group_label>
    <arm_group_label>PAR_2/18</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Measurement of physiological skin parameters</intervention_name>
    <description>Weekly measurement of physiological skin parameters using confocal Raman spectroscopy, Corneometer® CM 825, Sebumeter®, Skin-pH-Meter®, AquaFlux® and Epsilon®</description>
    <arm_group_label>IPM_2/18</arm_group_label>
    <arm_group_label>PAR_2/18</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tape stripping</intervention_name>
    <description>Removal of 40 adhesive strips after application of a model drug-loaded emulsion and determination of the transepidermal water loss</description>
    <arm_group_label>IPM_2/18</arm_group_label>
    <arm_group_label>PAR_2/18</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of subject informed consent

          -  Female or male aged between 18 and 65 years

        Exclusion Criteria:

          -  Pregnancy

          -  Chronic skin conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Vienna</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Lisa Binder</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Water-in-oil emulsion</keyword>
  <keyword>Confocal Raman spectroscopy</keyword>
  <keyword>Skin parameters</keyword>
  <keyword>Tape stripping</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

